CLDX
Celldex Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$38.24
−1.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1239.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.20x
- Price / sales
- —
- Price / cash flow
- -12.75x
Enterprise value
- Enterprise value
- $2.3B
- EV / sales
- —
- EV / EBITDA
- -7.71x
- EV / EBIT
- -7.03x
- Market cap
- $3.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026